T Rowe Price Group (TROW) 69.27 $TROW After Yes
Post# of 273257

After Yesterday's Decline of 1.09%, T Rowe Price Offers Investors Better Value
Comtex SmarTrend(R) - Thu Sep 01, 2:28PM CDT
T Rowe Price (NASDAQ:TROW) traded in a range yesterday that spanned from a low of $68.51 to a high of $69.98. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $68.77 on volume of 400,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TROW: 69.27 (+0.52)
T. Rowe Price Launches New Canadian Pooled Investment Vehicle Within Global Focused Growth Equity Strategy
CNW Group - Wed Aug 24, 9:00AM CDT
Global Focused Growth Equity strategy is now available to Canadian institutional investors through a new pooled vehicle
TROW: 69.27 (+0.52)
T. Rowe Price Group Declares Quarterly Dividend
PR Newswire - Wed Aug 24, 7:28AM CDT
T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced today that its Board of Directors has declared a quarterly dividend of $0.54 per share payable September 29, 2016 to stockholders of record as of the close of business on September 15, 2016.
TROW: 69.27 (+0.52)
Blog Coverage Valeant Pharma Appoints New CEO
ACCESSWIRE - Tue Aug 23, 8:15AM CDT
LONDON, UK / ACCESSWIRE / August 23, 2016 / Active Wall St. blog coverage looks at the headlines from Valeant Pharmaceuticals International, Inc. (NYSE: VRX) and Zoetis Inc. (NYSE: ZTS). Zoetis announced on August 21, 2016, that it had appointed Glenn David as its Executive Vice President and Chief Financial Officer (CFO). The announcement came in the wake of the resignation of Executive Vice President and CFO Paul S. Herendeen on August 18, 2016. On August, 22, 2016, Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced the appointment of Paul S. Herendeen to take on the role of CFO from Robert L. Rosiello. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.
AGN: 235.96 (-1.80), ZTS: 51.26 (+0.15), VRX: 28.76 (-0.36), TROW: 69.27 (+0.52), VRX.TO: 37.34 (-0.75)
Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:21AM CDT
Valeant Pharmaceuticals International, Inc. (VRX) announced that it has received the requisite lender approval for an amendment to its credit facility which is scheduled to close next week.
VRX: 28.76 (-0.36), TROW: 69.27 (+0.52), CORT: 5.31 (-0.04), PCRX: 39.04 (-1.33)
Company News for August 19, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:10AM CDT
Companies in the News are: CSCO,NTAP,HRL,VRX,TROW
VRX: 28.76 (-0.36), TROW: 69.27 (+0.52), HRL: 38.46 (+0.25), NTAP: 34.90 (-0.03), CSCO: 31.83 (+0.25)
T Rowe Price Falls 1.35% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Aug 09, 2:22PM CDT
T Rowe Price (NASDAQ:TROW) traded in a range yesterday that spanned from a low of $68.74 to a high of $69.78. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $68.80 on volume of 699,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TROW: 69.27 (+0.52)
Top 3 Research Reports for August 8, 2016
Sheraz Mian - Zacks Investment Research - Mon Aug 08, 11:27AM CDT
Top 3 Research Reports for August 8, 2016
CAH: 79.73 (+0.03), TROW: 69.27 (+0.52), KHC: 89.61 (+0.13), BAC: 16.00 (+0.02), AET: 116.73 (+0.57), MA: 97.89 (+0.27)
JPMorgan Partners with Virtu to Trade in U.S. Treasuries
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:21AM CDT
Wall Street giant JPMorgan Chase & Co. (JPM) entered into strategic partnership with a leading electronic market maker ??? Virtu Financial, Inc. (VIRT),to gain access and trade in the U.S. Treasuries market
VIRT: 16.27 (-0.19), JPM: 67.49 (+0.28), TROW: 69.27 (+0.52), CMA: 47.58 (+0.55)
Federated Investors (FII): High Revenues Drove Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:02PM CDT
Propelled by lower fee-waivers, Federated Investors, Inc. (FII) delivered a positive earnings surprise in second-quarter 2016, marking the fifth straight quarter of an earnings beat.
FII: 32.75 (+0.67), TROW: 69.27 (+0.52), JNS: 14.75 (+0.09), AMP: 101.11 (+1.22)
Lazard (LAZ) Q2 Earnings Impress on Low Costs, Shares Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 7:37AM CDT
Lazard Ltd. (LAZ) reported a positive surprise of 1.7% in second-quarter 2016 which led to a rise of 3.26% in its share price.
LAZ: 37.33 (+0.53), TROW: 69.27 (+0.52), JNS: 14.75 (+0.09), AMP: 101.11 (+1.22)
Asset Management Stocks Under Investors' Scanner -- T. Rowe Price Group, Ameriprise Financial, Federated Investors, and BlackRock
PR Newswire - Fri Jul 29, 6:50AM CDT
Growth in the Asset Management industry has stalled, as operators continue to address overcapacity issues and high operating costs. Stock-Callers.com looks at how these equities have performed in recent weeks despite these challenges: T. Rowe Price Group Inc. (NASDAQ: TROW), Ameriprise Financial Inc. (NYSE: AMP), Federated Investors Inc. (NYSE: FII), and BlackRock Inc. (NYSE: BLK). Learn more about these stocks by accessing their free notes at:
BLK: 373.85 (+1.68), FII: 32.75 (+0.67), TROW: 69.27 (+0.52), AMP: 101.11 (+1.22)
Franklin (BEN) Reports Impressive Q3 Earnings, Costs Down
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 1:54PM CDT
Franklin Resources Inc. (BEN) recorded a positive earnings surprise of 16.7% in third-quarter fiscal 2016 (ended Jun 30), driven by lower expenses. The company reported earnings of 77 cents per share, surpassing the Zacks Consensus Estimate of 66 cents.
TROW: 69.27 (+0.52), JNS: 14.75 (+0.09), AMP: 101.11 (+1.22), BEN: 36.15 (+0.29)
Legg Mason (LM) Q1 Earnings Miss Estimates on High Costs
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 6:51AM CDT
Legg Mason Inc. (LM) reported negative earnings surprise of 57.5% in the first quarter of fiscal 2017 (ended Jun 30). The company reported net income of 31 cents per share considerably missing the Zacks Consensus Estimate of 73 cents.
TROW: 69.27 (+0.52), JNS: 14.75 (+0.09), AMP: 101.11 (+1.22), LM: 34.78 (+0.73)
Janus Capital (JNS) Stock Up Despite Earnings Miss in Q2
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:05PM CDT
Janus Capital Group, Inc. (JNS) recorded a negative earnings surprise of 4.55% in second-quarter 2016. The company reported earnings per share attributable to common shareholders of 21 cents, missing the Zacks Consensus Estimate by a penny.
TROW: 69.27 (+0.52), IVZ: 31.48 (+0.38), JNS: 14.75 (+0.09), BEN: 36.15 (+0.29)
Zacks Research Daily for June 13, 2016
Sheraz Mian - Zacks Investment Research - Mon Jun 13, 1:26PM CDT
Zacks Research Daily for June 13, 2016
FIT: 14.96 (+0.01), TROW: 69.27 (+0.52), BAC: 16.00 (+0.02), INTC: 36.08 (+0.06), JNPR: 23.41 (+0.10)
T. Rowe Price to Cough Up $194M for the Dell Voting Error
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:14AM CDT
T. Rowe Price Group, Inc. (TROW), one of the biggest mutual-fund companies in the U.S., has arrived at an arrangement per which it will spend about $194 million to recompense certain clients.
APAM: 26.02 (+0.33), SEIC: 45.99 (+0.17), TROW: 69.27 (+0.52), GBL: 30.79 (+0.47)
T. Rowe Price To Compensate Clients For Dell Voting Error
PR Newswire - Mon Jun 06, 1:12PM CDT
NEWS
TROW: 69.27 (+0.52)

